UNH

Unitedhealth Group
D

UNH

Arincen63/100B
409.28
USD
5.31
(1.31%)
Post Trading·411.20USD+1.92(+0.47%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Unitedhealth Group return on equity (ROE)

Unitedhealth Group's return on equity is 16.01%: net income of 16.67B USD over the last twelve months on shareholders' equity of 104.13B USD.

Today
16.01%
Average, 5 years
20.87%
Low, 5 years
13.09%
High, 5 years
26.31%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 16.67B ÷ 104.13B = 16.01%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Unitedhealth Group's return on equity so high?

Net margin
2.7%
profit on each dollar of sales
Asset turnover
1.45×
sales on each dollar of assets
Equity multiplier
3.29×
assets on each dollar of equity
Return on equity
12.8%
FY2025
  • FY20252.7% × 1.45 × 3.29 = 12.8%
  • FY20243.6% × 1.34 × 3.22 = 15.5%
  • FY20236.0% × 1.36 × 3.08 = 25.2%
  • FY20226.2% × 1.32 × 3.16 = 25.9%
  • FY20216.0% × 1.36 × 2.96 = 24.1%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)
Today16.01%
FY202531 Dec 202513.61%
FY202431 Dec 202416.45%
FY202331 Dec 202325.22%
FY202231 Dec 202225.87%
FY202131 Dec 202124.09%
FY202031 Dec 202024.08%
FY201931 Dec 201924.02%
FY201831 Dec 201823.19%
FY201731 Dec 201721.19%
FY201631 Dec 201618.27%
FY201531 Dec 201517.24%
FY201431 Dec 201417.31%
FY201331 Dec 201317.50%
FY201231 Dec 201217.72%
FY201131 Dec 201118.17%
FY201031 Dec 201017.94%
FY200931 Dec 200916.19%
FY200831 Dec 200814.33%
FY200731 Dec 200723.20%
FY200631 Dec 200619.99%
FY200531 Dec 200518.61%
FY200431 Dec 200424.14%
FY200331 Dec 200335.59%
FY200231 Dec 200230.53%
FY200131 Dec 200123.46%
FY200031 Dec 200019.96%
FY199931 Dec 199914.70%
FY199831 Dec 1998-4.11%
FY199731 Dec 199710.15%
FY199631 Dec 19969.30%
FY199531 Dec 199513.40%
FY199431 Dec 1994-38.96%
FY199331 Dec 199320.29%
FY199231 Dec 199217.42%
FY199131 Dec 199123.47%
FY199031 Dec 199026.97%
FY198931 Dec 198922.72%
FY198831 Dec 1988-237.42%
FY198731 Dec 1987-38.07%
FY198631 Dec 198611.48%
FY198531 Dec 198513.73%

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Unitedhealth Group's ROE

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.